Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

JAZZ holding history

Jazz Pharmaceuticals plc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JAZZ overviewAll 13F holders of JAZZFull Q2 2026 holdings

Shares (Q2 2026)
1,006,676
Value
$242.6M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of JAZZ by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,006,676$242.6M0.1%−252,768−20.1%ReducedHolders
Q1 20261,259,444$238.1M0.2%+948,324+304.8%AddedHolders
Q4 2025311,120$52.9M<0.1%−572,825−64.8%ReducedHolders
Q3 2025883,945$116.5M0.1%+261,773+42.1%AddedHolders
Q2 2025622,172$66.0M0.1%−74,772−10.7%ReducedHolders
Q1 2025696,944$86.5M0.1%+190,596+37.6%AddedHolders
Q4 2024506,348$62.4M0.1%−547,173−51.9%ReducedHolders
Q3 20241,053,521$117.4M0.1%+664,822+171.0%AddedHolders
Q2 2024388,699$41.5M<0.1%+378,042+3,547.4%AddedHolders
Q1 202410,657$1.28M<0.1%−19,609−64.8%ReducedHolders
Q4 202330,266$3.72M<0.1%+15,282+102.0%AddedHolders
Q3 202314,984$1.94M<0.1%−87,816−85.4%ReducedHolders
Q2 2023102,800$12.7M<0.1%−169,769−62.3%ReducedHolders
Q1 2023272,569$39.9M<0.1%−355,919−56.6%ReducedHolders
Q4 2022628,488$100.1M0.1%+628,488NewHolders
Q3 20220$00.0%−707,226−100.0%Sold outHolders
Q2 2022707,226$110.3M0.2%+176,935+33.4%AddedHolders
Q1 2022530,291$82.5M0.1%+443,622+511.9%AddedHolders
Q4 202186,669$11.0M<0.1%+39,229+82.7%AddedHolders
Q3 202147,440$6.18M<0.1%−915,032−95.1%ReducedHolders
Q2 2021962,472$171.0M0.2%−384,050−28.5%ReducedHolders
Q1 20211,346,522$221.3M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.